Losartan Potassium Tablet, Film Coated
Product Images NDC 72603-340

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 72603-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losartanpotassiumfigure1 (Losartanpotassiumfigure1)

This text provides information about the percentage of patients with the primary endpoint in a study comparing Atenolol and Losartan potassium. It also mentions an adjusted risk reduction of 13% with a p-value of 0.021. Additionally, it displays the study month timeline from 6 to 66 months.*

FDA Label Image

Losartanpotassiumfigure2 (Losartanpotassiumfigure2)

FDA Label Image

Losartanpotassiumfigure3 (Losartanpotassiumfigure3)

The text contains data related to a study comparing the effectiveness of Losartan Potassium and Atenolol in patients with certain characteristics such as age, gender, diabetes, and history of CVD. The study analyzed the event rates (%), hazard ratios, and outcomes such as stroke (Fatal/Non-Fatal). The results suggest that Losartan Potassium may have a favorable outcome compared to Atenolol in the study population.*

FDA Label Image

Losartanpotassiumfigure4 (Losartanpotassiumfigure4)

This description provides the percentage of patients with the event, showing 60% for one group and 40% for the other. It also states a risk reduction of 16.1% with a p-value of 0.022. The comparison is between Losartan Potassium and Placebo.*

FDA Label Image

Losartanpotassiumlabel100mg90s (Losartanpotassiumlabel100mg90s)

This text provides information about Losartan Potassium tablets USP, each film-coated tablet containing 100 mg of the active ingredient. The recommended adult dosage and storage instructions are included, along with a warning to keep the medication out of the reach of children. It also mentions the manufacturer and distributor details for the product.*

FDA Label Image

Losartanpotassiumlabel25mg90s (Losartanpotassiumlabel25mg90s)

This is a description of a medication called Losartan Potassium Tablets USP, with each film-coated tablet containing 25 mg of Losartan Potassium USP. The medication comes in a package containing 90 tablets. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) and should be kept away from light. It also includes a warning to keep the medication out of reach of children. The medication is manufactured for Northstar Rx LLC in Memphis, Tennessee, by Hetero Labs Limited in India. For full prescribing information, refer to the package insert.*

FDA Label Image

Losartanpotassiumlabel50mg90s (Losartanpotassiumlabel50mg90s)

This description is not readable.*

FDA Label Image

Losartanpotassiumstructure (Losartanpotassiumstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.